Board meeting on 12 October 2026 to consider NCD issuance of up to INR 15,000 Crore
Board meeting scheduled for Monday, 12 October 2026.
- Board Meeting Date
- Monday, 12 October 2026
- NCD Issue Size
- not exceeding INR 15,000 Crore (Indian Rupees Fifteen Thousand Crore only)
- Issue Basis
- listed, rated, unsecured, redeemable non-convertible debentures (NCDs), in one or more tranches, on a private placement basis
What the company has informed the exchanges
- A meeting of the Board of Directors is scheduled for Monday, 12 October 2026.
- Among the items to be considered is the issuance of listed, rated, unsecured, redeemable non-convertible debentures, referred to as NCDs.
- The issuance is proposed in one or more tranches, on a private placement basis.
- The aggregate amount is not exceeding INR 15,000 Crore (Indian Rupees Fifteen Thousand Crore only).
- The Board will also consider matters incidental and connected to the issuance.
What an NCD is, in simple words
An NCD is a debenture, a form of borrowing. The company raises money from investors, pays interest on it, and repays the amount at maturity.
- Listed means the debentures are intended to be listed on an exchange.
- Rated means they carry a credit rating.
- Unsecured means they are not backed by a specific asset of the company.
- Redeemable means they have a fixed maturity, when the money is returned.
- Private placement means the debentures are offered to select investors and not to the general public.
The key figure
- Aggregate size proposed to be considered: not exceeding INR 15,000 Crore.
How to read this
- The update describes an item placed before the Board. The words used are to consider and approve, so this is a proposal at this stage.
- The money raised through debentures is borrowed money. Using this route does not add new equity shares, so the shareholding of existing shareholders is not diluted by the issue of these instruments.
- The debentures carry a rating and are proposed to be listed, which are features investors can note along with the terms that are decided when the issuance is approved.
What happens next
The outcome of the Board meeting scheduled for 12 October 2026, where the issuance and connected matters will be considered and approved.
Also from Sun Pharmaceutical Industries
Announces $2.5 million endowed dermatology professorship at Mount Sinai
6 Oct 2026
LEQSELVI two-year data in severe alopecia areata shows sustained efficacy at EADV Congress 2026
1 Oct 2026
ESG Overview for FY 2025-26 submitted to exchanges
29 Sep 2026
More numbers
- Maximum aggregate size of proposed NCD issuanceINR 15,000 Crore
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.